Critical care pandemic preparedness primer

Intensive Care Medicine: Annual Update 2007

Volumn , Issue , 2007, Pages 999-1010

  Christian, M D ^a   Lapinsky, S E ^b   Stewart, T E ^b  

^a MCMASTER UNIVERSITY   (Canada)

^b MOUNT SINAI HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84892087756     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-0-387-49518-7_91     Document Type: Chapter

References (50)

1. Christian MD, Poutanen SM, Loutfy MR, Muller MP, Low DE (2004) Severe acute respiratory syndrome. Clin Infect Dis 38:1420-1427
2. Bush LM, Abrams BH, Beall A, Johnson CC (2001) Index case of fatal inhalational anthrax due to bioterrorism in the United States. N Engl J Med 345:1607-1610
3. Webster RG, Peiris M, Chen H, Guan Y (2006) H5N1 outbreaks and enzootic influenza. Emerg Infect Dis 12:3-8
4. Olsen B, Munster VJ, Wallensten A, Waldenstrom J, Osterhaus AD, Fouchier RA (2006) Global patterns of influenza a virus in wild birds. Science 312:384-388
5. Osterholm MT (2005) Preparing for the next pandemic. N Engl J Med 352:1839-1842
6. Fauci AS (2006) Pandemic influenza threat and preparedness. Emerg Infect Dis 12:73-77
7. Kilbourne ED (2006) Influenza pandemics of the 20th century. Emerg Infect Dis 12:9-14
8. Beigel JH, Farrar J, Han AM, et al (2005) Avian influenza A (H5N1) infection in humans. N Engl J Med 353:1374-1385
9. Taubenberger JK Morens DM (2006) 1918 Influenza: the mother of all pandemics. Emerg Infect Dis 12:15-22
10. Anderson TA, Hart GK, Kainer, MA (2003) Pandemic influenza-implications for critical care resources in Australia and New Zealand. J Crit Care 18:173-180
11. Nicholson KG, Wood JM, Zambon M (2003) Influenza. Lancet 362:1733-1745
12. Kuiken T, Holmes EC, McCauley J, Rimmelzwaan GF, Williams CS, Grenfell BT (2006) Host species barriers to influenza virus infections. Science 312:394-397
13. Belshe RB (2005) The origins of pandemic influenza-lessons from the 1918 virus. N Engl J Med 353:2209-2211
14. Carrat F, Tachet A, Rouzioux C, Housset B, Valleron AJ (1999) Evaluation of clinical case definitions of influenza: detailed investigation of patients during the 1995-1996 epidemic in France. Clin Infect Dis 28:283-290
15. Monmany J, Rabella N, Margall N, Domingo P, Gich I, Vazquez G (2004) Unmasking influenza virus infection in patients attended to in the emergency department. Infection 32:89-97
16. Gruber PC, Gomersall CD, Joynt GM (2006) Avian influenza (H5N1): implications for intensive care. Intensive Care Med 32:823-829
17. Call SA, Vollenweider MA, Hornung CA, Simel DL, McKinney WP (2005) Does this patient have influenza? JAMA 293:987-997
18. Monto AS, Gravenstein S, Elliott M, Colopy M, Schweinle J (2000) Clinical signs and symptoms predicting influenza infection. Arch Intern Med 160:3243-3247
19. Jefferson T, Rivetti D, Rivetti A, Rudin M, Di Pietrantonj C, Demicheli V (2005) Efficacy and effectiveness of influenza vaccines in elderly people: a systematic review. Lancet 366:1165-1174
20. Moscona A (2005) Neuraminidase inhibitors for influenza. N Engl J Med 353:1363-1373
21. Salgado CD, Farr BM, Hall KK, Hayden FG (2002) Influenza in the acute hospital setting. Lancet Infect Dis 2:145-155
22. Monto AS (2006) Vaccines and antiviral drugs in pandemic preparedness. Emerg Infect Dis 12:55-60
23. Hoelscher MA, Garg S, Bangari, DS, et al (2006) Development of adenoviral-vector-based pandemic influenza vaccine against antigenically distinct human H5N1 strains in mice. Lancet 367:475-481
24. Luke CJ, Subbarao K (2006) Vaccines for pandemic influenza. Emerg Infect Dis 12:66-72
25. Treanor JJ, Campbell JD, Zangwill KM, Rowe T, Wolff M (2006) Safety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccine. N Engl J Med 354:1343-1351
26. Ferguson NM, Cummings DA, Cauchemez S, et al (2005) Strategies for containing an emerging influenza pandemic in Southeast Asia. Nature 437:209-214
27. Gani R, Hughes H, Fleming D, Griffin T, Medlock J, Leach S (2005) Potential impact of antiviral drug use during influenza pandemic. Emerg Infect Dis 11:1355-1362
28. Lee VJ, Phua KH, Chenm MI, et al (2006) Economics of neuraminidase inhibitor stock piling for pandemic influenza, Singapore. Emerg Infect Dis 12:95-102
29. de Jong MD, Tran TT, Truong HK, et al (2005) Oseltamivir resistance during treatment of influenza A (H5N1) infection. N Engl J Med 353:2667-2672
30. Jefferson T, Demicheli V, Rivetti D, Jones M, Di Pietrantonj C, Rivetti A (2006) Antivirals for influenza in healthy adults: systematic review. Lancet 367:303-313
31. Hayden FG (2006) Antiviral resistance in influenza viruses-implications for management and pandemic response. N Engl J Med 354:785-788
32. Bridges CB, Kuehnert MJ, Hall CB (2003) Transmission of influenza: implications for control in health care settings. Clin Infect Dis 37:1094-1101
33. Muller MP, McGeer A (2006) Febrile respiratory illness in the intensive care unit setting: an infection control perspective. Curr Opin Crit Care 12:37-42
34. Centers for Disease Control and Prevention (2005) Infection Control Guidance for the Prevention and Control of Influenza in Acute-Care Facilities. Available at: http://www.cdc.gov/flu/professionals/infectioncontrol/pdf/flu- infectioncontrol-hcfacilities.pdf. Accessed November, 2006
35. Centers for Disease Control and Prevention (2004) Interim Recommendations for Infection Control in Health-Care Facilities Caring for Patients with Known or Suspected Avian Influenza. Available at: http://www.cdc.gov/flu/avian/ professional/infect-control.htm Accessed November, 2006
36. Schoch-Spana M (2000) Implications of pandemic influenza for bioterrorism response. Clin Infect Dis 31:1409-1413
37. Bell DM (2006) Non-pharmaceutical interventions for pandemic influenza, national and community measures. Emerg Infect Dis 12:88-94
38. Mounier-Jack S, Coker RJ (2006) How prepared is Europe for pandemic influenza? Analysis of national plans. Lancet 367:1405-1411
39. Ministry of Health and Long-Term Care (2006) Ontario Health Plan for an Influenza Pandemic. Available at: http://www.health.gov.on.ca/english/providers/ program/emu/pan-flu/pan-flu-plan.html. Accessed Nomember 2006
40. Booth CM, Stewart TE (2003) Communication in the Toronto critical care community: important lessons learned during SARS. Crit Care 7:405-406
41. Hawryluck L, Lapinsky S, Stewart T (2005) Clinical review: SARS-lessons in disaster management. Critl Care 9:384-389
42. Christian MD, Kollek D, Schwartz B (2005) Emergency preparedness: What every healthcare worker needs to know. Can J Emerg Med 7:330-337
43. Gold W, Hawryluck L, Robinson S, McGreer A, Styra R (2003) Post-traumatic stress disorder among healthcare workers at a hospital treating patients with SARS. ICAAC Abstract Book 750a (abst)
44. University of Toronto Joint Centre for Bioethics Pandemic Influenza Working Group (2005) Stand On Guard For Thee: Ethical considerations in preparedness planning for pandemic influenza. Available at; http://www.utoronto. ca/jcb/home/documents/pandemic.pdf. Accessed November 2006
45. Hick JL, Hanfling D, Burstein JL, et al (2004) Health care facility and community strategies for patient care surge capacity. Ann Emerg Med 44:253-261
46. Rubinson L, Nuzzo JB, Talmor DS, O'Toole T, Kramer BR, Inglesby TV (2005) Augmentation of hospital critical care capacity after bioterrorist attacks or epidemics: recommendations of the Working Group on Emergency Mass Critical Care. Crit Care Med 33:2393-2403
47. Rubinson L, O'Toole T (2005) Critical care during epidemics. Crit Care 9:311-313
48. Domres B, Koch M, Manger A, Becker HD (2001) Ethics and triage. Prehospital Disaster Med 16:53-58
49. Christian MD, Hawryluck L, Wax RS, et al (2006) Development of a triage protocol for critical care during a pandemic. CMAJ 175:1377-1381
50. Ferreira FL, Bota DP, Bross A, Melot C, Vincent JL (2001) Serial evaluation of the SOFA score to predict outcome in critically ill patients. JAMA 286:1754-1758